Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10230/34219
dc.contributor.author | Hernández Llodrà, Sílvia |
---|---|
dc.contributor.author | Juanpere, Nuria |
dc.contributor.author | Muga, Silvia de |
dc.contributor.author | Lorenzo Perez, Marta |
dc.contributor.author | Gil Ortega, Joan |
dc.contributor.author | Font Tello, Alba 1990- |
dc.contributor.author | Agell, Laia |
dc.contributor.author | Albero-González, Raquel |
dc.contributor.author | Segalés, Laura |
dc.contributor.author | Merino, José |
dc.contributor.author | Serrano, Laia |
dc.contributor.author | Fumadó Ciutat, Lluis |
dc.contributor.author | Cecchini Rosell, Lluís |
dc.contributor.author | Lloreta Trull, Josep, 1958- |
dc.date | 2017 |
dc.identifier.citation | Hernández-Llodra S, Juanpere N, de Muga S, Lorenzo M, Gil J, Font-Tello A et al. ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression. Oncotarget. 2017 May 26;8(43):74106-74118. DOI: 10.18632/oncotarget.18266. eCollection 2017 Sep 26 |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | http://dx.doi.org/10.18632/oncotarget.18266 |
dc.identifier.uri | http://hdl.handle.net/10230/34219 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation | Oncotarget. 2017 May 26;8(43):74106-74118 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | © Hernández-Llodrà et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0) (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
dc.rights | http://creativecommons.org/licenses/by/3.0/ |
dc.subject | ERG |
dc.subject | PTEN |
dc.subject | SLC45A3 |
dc.subject | Progression |
dc.subject | Prostate cancer |
dc.title | ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |